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Edited by Angel NebredaAbstract In the present paper, we have studied the expression
of the Phosphatase and TENsin homolog deleted on chromosome
10 (PTEN) and its putative biological role in the sheep ovary.
We found by Northern-blot, immunohistochemistry and immuno-
blot that PTEN is highly expressed in granulosa cells from large
diﬀerentiated follicles (LF) in comparison with small proliferat-
ing follicles (SF) (P < 0.001), with no clear eﬀect of follicle qual-
ity. Moreover, the PTEN lipid phosphatase activity is also
higher in LF than in SF (P < 0.01). In contrast, levels of the
phosphorylated form of AKT (pAKT) are lower in LF than in
SF (P < 0.0001). IGF-I and insulin but not FSH, LH or for-
skolin are able to stimulate the expression of PTEN mRNA
(P < 0.001) and protein by ovine granulosa cells after 48 h of cul-
ture in vitro. An IGF-1 time course analysis showed that expres-
sion of PTEN protein appeared after 12 h of culture,
concomitant with the fall of the pAKT levels, which peaked after
6 h of stimulation with IGF-I. Moreover, transfection experi-
ments showed that overexpression of PTEN in ovine granulosa
cells induced a decrease and an increase in E2F and p27 pro-
moter activity, respectively (P < 0.05). Overall, our present data
show for the ﬁrst time that the expression of PTEN increases
during terminal follicular growth. This increase, that might be in-
duced by IGF-I but not FSH, would participate in the prolifera-
tion/diﬀerentiation transition of ovine granulosa cells in
diﬀerentiating follicles.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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In the ovary of all mammalian species, basal follicular
development is associated with a high proliferation rate of
granulosa cells. During terminal follicular growth, the prolif-
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doi:10.1016/j.febslet.2005.03.036come highly steroidogenic. In the sheep ovary, this
proliferation/diﬀerentiation transition occurs in 2–4 mm
diameter follicles, ovulation occurring at 6–7 mm diameter
[1]. The maturation of follicles is under the control of at
least two major hormonal regulators, follicle stimulating
hormone (FSH) and insulin-like growth factor-I (IGF-I).
In the ewe, as also shown in other domestic species includ-
ing cow [2] and sow [3], IGF-1 stimulates proliferation of
granulosa cells from small growing (1–3 mm diameter in
the sheep) follicles, and secretion of progesterone by granu-
losa from highly steroidogenic (>5 mm diameter in the
sheep) follicles [4]. The biological functions of the IGFs
are mainly mediated by the type-I IGF receptor (IGF-IR)
that is able to activate the phosphatidylinositol 3-kinase
(PI3K)/protein kinase B (AKT) pathway and the mitogen
activated protein kinase pathway (MAPK, also known as
the extracellular-regulated kinase (ERK) pathway) [5]. In
particular, activation of the PI3K or the MAPK pathway
by IGF-1 has been reported to stimulate proliferation, but
also diﬀerentiation and/or cell survival depending on the cell
type [6,7]. For example, in cow granulosa cells, IGF-1 pro-
tects cells from FAS-L-induced apoptosis by stimulating the
PI3K/AKT pathway [8]. In human granulosa cells, IGF-1-
induced stimulation of progesterone requires the MAPK
activation [9].
One of the negative regulators of IGF-IR signalling path-
ways is the tumour suppressor gene PTEN (phosphatase and
tensin homolog deleted on chromosome 10). PTEN is a lipid
and protein phosphatase which is able to dephosphorylate
the phosphatidylinositol-3,4,5-triphosphate (PIP3) to the
phosphatidylinositol-3,4-triphosphate (PIP2). As PIP3 is
known to activate PDK1 that phosphorylates AKT, PTEN
indirectly inhibits AKT phosphorylation [10]. PTEN blocks
also the phosphorylation of insulin receptor substrate-1
(IRS-1) and impairs insulin-induced phosphorylation of
MAPK pathway in breast cancer cells [11]. Moreover, over-
expression of PTEN in vivo and vitro in diﬀerent cell lines
induces the arrest of cell cycle and/or apoptosis [12–14]. In
contrast, deletion or loss-of-function mutations of PTEN
are implicated in a variety of human cancers, including pros-
tate, breast, brain, as well as endometrial and ovarian can-
cers [15,16]. In human endometrium, PTEN expression has
been shown to increase several fold in secretory compared
to proliferative endometrium [17]. The aim of the present
study was to test the hypothesis that PTEN is also expressed
in diﬀerentiating rather than proliferative ovine granulosa
cells in vivo.blished by Elsevier B.V. All rights reserved.
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2.1. Materials
Fluorogestone acetate sponges used to synchronize estrous cycles
were obtained from Intervet (Angers, France). Porcine FSH (pFSH)
from pituitary extract (pFSH activity = 1.15 times activity of NIH
pFSH-P1) used for injections to animals was obtained from Dr. Y.
Combarnous (Nouzilly, France). Puriﬁed ovine FSH-20 (oFSH) (lot
no. AFP-7028D, 4453 IU/mg, FSH activity = 175 times activity of
oFSH-S1) used for culture treatment was a gift from NIDDK (Na-
tional Hormone Pituitary Program, Bethesda, MD, USA). Recombi-
nant human insulin-like growth factor-I (IGF-I) was a gift from Dr.
P. Swift (Ciba-Geigy, Saint Aubin, Switzerland). Insulin and Forskolin
were obtained from SIGMA. Ovine Luteinizing Hormone (oLH) was
obtained from Dr. Y. Combarnous (Nouzilly, France).
2.2. Animals
All procedures were approved by the Agricultural Agency and the
Scientiﬁc Research Agency (approval number A 37801) and con-
ducted in accordance with the guidelines for Care and Use of Agri-
cultural Animals in Agricultural Research and Teaching. Fifty adult
cyclic Romanov ewes were treated with intravaginal sponges impreg-
nated with progestagen (ﬂuorogestone acetate, 40 mg) for 15 days to
mimic a luteal phase. Cells for culture were collected from animals
in the luteal phase of the estrous cycle (10 days after sponge re-
moval, plus intramuscular injections of 6 IU and 5 IU pFSH 24
and 12 h prior to slaughter, respectively). Moreover, the ovaries
from ﬁve ewes (three in follicular phase and two in luteal phase)
were ﬁxated in Bouin solution and included in paraﬃn until immu-
nohistochemistry experiments.
2.3. Culture and transfection of granulosa cells
Culture and transfections of granulosa cells and reagents were de-
scribed previously [18]. In particular, culture medium contained
100 lg/l insulin and 10 lg/l IGF-I. Cells were transfected with
1 lg/well of a vector overexpressing human PTEN, PBK-CMV-
PTEN (PTEN sense) as previously described [13], or a control
PBK-CMV empty vector, associated with 1 lg/well of a vector con-
taining E2F responsive elements (E2F-TK-Luc) [19] or p27 promoter
[20] driving the ﬁreﬂy luciferase gene. Twenty ﬁve ng of renilla lucif-
erase plasmid were also transfected to normalize transfection eﬃ-
ciency. After 48 h of culture in presence of IGF-1 10 ng/ml to
activate the E2F activity, cells were lysated and both ﬁreﬂy and re-
nilla luciferase activities were quantiﬁed on a luminometer (TD-20/
20, Turner Designs, Sunnyvale, CA, USA). Each combination of
treatment was tested in triplicate in at least three independent cul-
tures. All the values are represented as a percentage of the control.
Previous results using another plasmid containing a GFP-domain
fused to PTEN protein (GFP-PTEN sense plasmid as previously de-
scribed [14]) allowed us to estimate the percentage (15–20%) of
transfected cells (data not shown).
2.4. RNA extraction and Northern blot
For Northern blot experiments, follicles were dissected and total
RNA was extracted from granulosa cells from small (1–3 mm diame-
ter; SF) and large (>5 mm diameter; LF) follicles using RNAble re-
agent according to the manufacturers procedure (Eurobio, Les Ulis,
France). Total RNA (20 lg) was separated by denaturing formalde-
hyde electrophoresis, then transferred to a nylon membrane by capil-
larity overnight, immobilized by exposure to UV light, and
submitted to prehybridization and hybridization procedures as previ-
ously described [14]. Expression of PTEN was analyzed using the en-
tire 1.2 kb human cDNA PTEN as a probe. RNA levels were
quantiﬁed using a phosphoImager apparatus (Molecular Dynamics,
Bondouﬂe, France). The integrity of diﬀerent transcripts was assessed
using the human RNA 18S probe from Ambion (Austin, TX, USA).2.5. Analysis of protein expression
For immunohistochemistry experiments, ovaries included in paraﬃn
were serially sectioned at a thickness of 10 lm. Sections were then
deparaﬃnized, and submitted to immunohistochemistry using mouse
primary antibody raised against PTEN (1:1000, gift from C. Eng,
USA) as previously described [21].For Western-immunoblot experiments comparing PTEN expression
in SF and LF, granulosa cells were recovered, independently of their
quality, and cell lysates were submitted to SDS–PAGE. For Wes-
tern-immunoblot experiments comparing PTEN expression in healthy
versus atretic follicles, granulosa cells from each SF and LF were indi-
vidually recovered, and the degree of atresia of each follicle was as-
sessed after staining a smear of granulosa cells with Feulgen. As
previously described [22], follicles were judged normal or atretic using
classical histological criteria (normal: frequent mitosis, no pyknosis in
granulosa cells; atretic: no mitosis, frequent pyknotic bodies in granu-
losa cells). The rest of granulosa cells was individually stored at
70 C. Afterward, granulosa cells from small healthy, small atretic,
large healthy and large atretic follicles were pooled. In both cases, cell
lysates of granulosa cells were prepared on ice in lysis buﬀer (10 mM
Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 0.5%
Igepal) containing various protease inhibitors (2 mM PMSF, 10 mg/
ml leupeptin, and 10 mg/ml aprotinin) and phosphatase inhibitors
(100 mM sodium ﬂuoride, 10 mM sodium pyrophosphate, and 2 mM
sodium orthovanadate (Sigma, lIsle dAbeau Chesnes, France)). Cell
extracts were then submitted to electrophoresis and Western-immuno-
blotting using rabbit antibodies raised against PTEN (ﬁnal dilution
1:1000, Cell signaling), steroidogenic acute regulatory protein (StAR;
a gift from Dr. D.B. Hales, Chicago, USA), phosphorylated AKT
(pAKT) on Ser473 (ﬁnal dilution 1:1000, Cell signaling), and phos-
phorylated MAPK ERK1/2 (ﬁnal dilution 1:1000, Cell signaling).
The blots were then stripped and reblotted with antibodies raised
against AKT, MAP kinase ERK1/2, actin or tubulin (ﬁnal dilution
1:1000, Cell signaling) to determine total proteins loading. The signals
were detected by ECL (enhanced chemiluminescence, Amersham Phar-
macia Biotech, Orsay, France) and quantiﬁed with the software Mac
Bas V2.52 (Fuji Photo Film). The results were expressed as the ratio
of stimulation as compared with the control (unstimulated cells). Val-
ues represent the means ± S.E.M. from four independent experiments.
2.6. Immunoprecipitation and phosphatase assay
Two aliquots of granulosa cell protein extracts containing 400 lg of
protein from large and small follicles were incubated overnight with a
rabbit polyclonal anti-PTEN antibody and immunoprecipitated on
protein G agarose beads (Santa Cruz Biotechnology, CA, USA). Then,
phosphatase assay was performed with the ﬁrst aliquot of lysate and
Western-blot using rabbit anti-PTEN antibody was realized in parallel
with the second lysate to determine the amount of PTEN protein in the
immunoprecipitates. For the phosphatase assay, after immunoprecipi-
tation, the beads were washed twice in a low-stringency buﬀer contain-
ing 20 mM HEPES (pH 7.7), 50 mM NaCl, 0.1 mM EDTA and
2.5 mM MgCl2 and once in phosphatase assay buﬀer containing
100 mM Tris–HCl pH 8, 10 mM DTT lacking PIP3. The reaction
was performed in 50 ll of the assay buﬀer containing 200 lM water-
soluble diC8-PIP3 (Echelon, Salt Lake City) and then incubated for
40 min at 37 C and transferred to a 96-well plate. The release of phos-
phate from the substrate was measured in a colorimetric assay by using
the Biomol Green Reagent (Biomol) in accordance with the instruc-
tions of the manufacturer. The absorbance at 650 nm was recorded
in an ELISA plate reader. A standard curve was performed in each as-
say, and the amount of free phosphate was calculated from the stan-
dard curve line-ﬁt data. Western-blot was performed as described
above.
2.7. Statistical analysis
All experimental data are presented as the means ± S.E.M. The ef-
fects of PTEN on E2F-TK-Luc and p27-Luc activity, the PTEN phos-
phatase activity levels and the signals obtained by Northern-blot and
Western-immunoblot were analyzed using paired t-test.3. Results and discussion
3.1. Expression and functionality of PTEN in ovine ovary
By immunohistochemistry, the PTEN protein was observed
in granulosa cells from large (>5 mm diameter; LF) but not
small (1–3 mm diameter; SF) antral follicles with no clear
relationship with the degree of atresia of the follicles (Fig. 1A).
Fig. 1. Expression of PTEN in ovine ovary. (A) Localization of PTEN protein by immunohistochemistry. 1–3: large atretic follicle; 4–6: large healthy
follicle; 7–9: small healthy follicle; 10–12: Negative control (section incubated with non-immune serum). Note that PTEN expression is observed
speciﬁcally in granulosa cells (G) from healthy and atretic LF. G, granulosa cells; T, thecal cells. Scale bar = 50 lm. Magniﬁcation (·): 2.5-fold (1, 4,
7, 10); 20-fold (2, 5, 8, 11) and 40-fold (3, 6, 9, 12). (B) Northern blot analysis of PTEN expression. Northern blot was performed using total RNA
isolated from SF and LF as described in Section 2. The blot was ﬁrst hybridized with the full length human PTEN probe followed by a 18S control
probe. Note that PTEN mRNA was highly expressed in granulosa cells from LF in comparison with SF. (C) Quantiﬁcation of the Northern blots.
\\\P < 0.001, n = 4.
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not shown). By Northern blot analysis, granulosa cells from
LF were shown to express higher levels of PTEN mRNA
than granulosa cells from SF (P < 0.001, n = 4; Fig. 1B and
C), suggesting that PTEN expression increases during termi-
nal follicular growth. Immunoblotting on protein extracts
conﬁrmed that PTEN levels were higher in cell lysates of
granulosa cells from LF than SF (Fig. 2A and B
P < 0.001). Interestingly, the levels of pAKT, an indirect
downstream target of PTEN, were lower in granulosa cell
protein extracts from LF than in SF (Fig. 2A and B
P < 0.001). These results are in good agreement with previous
studies in some primary epithelial ovarian carcinomas where
the PTEN expression was shown to be inversely correlated
with the phosphorylation of AKT [16]. In our study, the
PTEN lipid-phosphatase activity was about two-fold higher
in freshly dissected granulosa cells from LF in comparisonwith SF (P < 0.01, Fig. 3A), and the level of PTEN protein
in the corresponding immunoprecipitates was also about
two-fold (1.85-fold, P < 0.05) higher in LF than in SF (Fig.
3B), demonstrating that the diﬀerence in PTEN phosphatase
activity was mainly due to a diﬀerence in PTEN protein level.
Finally, by immunoblotting, we observed no diﬀerence in the
amount of PTEN as well as phosphorylated and non-phos-
phorylated forms of AKT and ERK in healthy versus atretic
small follicles (Fig. 2C and D), conﬁrming data obtained by
immunohistochemistry and suggesting that the expression of
PTEN is not clearly associated with the quality of follicles.
Overexpression of PTEN in mouse mammary gland in vivo
[14] or in PC3 human prostate cancer cells in vitro [13] is able
to induce apoptosis. In the present work, one can hypothesize
that the PTEN expression level in ovine ovarian LF might
not be suﬃcient to induce apoptosis. Alternatively, the bio-
logical role of PTEN could depend on the cell type.
Fig. 2. Detection of PTEN protein by immunoblotting in ovine granulosa cells. (A) Proteins extracts (50 lg) from granulosa cells from SF and LF
were subjected to SDS–PAGE electrophoresis, transferred to a nitrocellulose membrane, and incubated with speciﬁc antibodies raised against PTEN,
AKT, pAKT and actin as described in Section 2. The immunoblotting with anti-actin served as a loading control. Results are representative of at
least three independent experiments. SF: small follicles; LF: large follicles. (B) Quantiﬁcation of the immunoblots. \\\, P < 0.001, n = 3. (C) Proteins
extracts (50 lg) from granulosa cells from four pools of healthy and atretic SF were subjected to SDS–PAGE electrophoresis, transferred to a
nitrocellulose membrane, and incubated with a speciﬁc antibody raised against PTEN, phosphorylated and non-phosphorylated forms of AKT and
Erk1/2 as described in Section 2. Results are representative of at least three independent experiments. SF: small follicles; LF: large follicles. (D)
Quantiﬁcation of the immunoblots; no signiﬁcant diﬀerences were observed (n = 3).
Fig. 3. PTEN phosphatase activity. (A) Granulosa cells protein
extracts from SF and LF (400 lg protein per sample) were subjected
to immunoprecipitation with the PTEN polyclonal antibody and the
phosphatase activity of PTEN was measured as described in Section 2.
n = 4; \\, P < 0.01. (B) Immunoblot of the granulosa cells protein
extracts from SF and LF (400 lg protein per sample) after immuno-
precipitation with the PTEN polyclonal antibody. Note that the
amount of PTEN protein immunoprecipitated in the corresponding
samples was about two-fold higher in LF compared to SF.
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creases during the proliferation/diﬀerentiation transition of
granulosa cells at the end of ovine follicular growth, and isnot clearly associated with follicular atresia. Interestingly, such
an increase in PTEN expression has also been described during
the proliferation/diﬀerentiation transition of human endome-
trial cells [17].
3.2. PTEN expression is regulated by IGF-I and insulin but not
FSH in vitro
IGF-1 and FSH are the most important regulators of ovine
granulosa cell proliferation [4]. Thus, we have tested whether
these two mitogens could modify the PTEN expression in these
cells. In vitro, a 48 h treatment with IGF-I (100 ng/ml) en-
hanced PTEN mRNA (control, 3.61 ± 2.61 arbitrary units
(AI), versus 49.10 ± 2.47 n = 3, P < 0.001) and protein expres-
sion (control, 2.1 ± 2 (AI), versus 20 ± 5, n = 3, P < 0.05) by
granulosa cells from SF (Fig. 4). A similar increase was ob-
tained after stimulation by insulin (100 ng/ml) (Fig. 4). The in-
crease in PTEN protein was observed after 12 h of stimulation,
concomitant with the fall of pAKT levels that peaked after 6 h
of stimulation with IGF-I (Fig. 5). FSH, LH and forskolin
were without any eﬀect on PTEN mRNA and protein expres-
sion. On the contrary, as expected, FSH and Forskolin were
able to stimulate steroidogenic acute regulatory protein
(StAR) protein expression, a protein involved in the transfer
of cholesterol into the mitochondria, which is a key step for
the steroidogenesis (Fig. 4). Thus, IGF-I could induce PTEN
expression in granulosa cells to modulate its physiologic
eﬀects.
Moorehead et al. [23] have shown that in mammary gland
IGF-II is also able to induce the expression of PTEN. Further-
more, in prostate cancer cells, overexpression of PTEN was
shown to reduce IGF-1R levels [13], suggesting the existence
Fig. 4. Regulation of PTEN expression in vitro in ovine granulosa
cells. (A) Granulosa cells from SF were cultured for 48 h in the absence
(C: control) or in the presence of IGF-I (100 ng/ml), insulin (100 ng/ml
each) or FSH (50 ng/ml). Total RNA isolated from these cells was
subjected to Northern blot analysis as described in Section 2. The blot
was ﬁrst hybridized with the full length PTEN probe followed by a
control 18S probe. The blots are representative of three independent
experiments. (B) Protein extracts (60 lg) from SF cultured for 48 h in
absence (C: control) or in presence of FSH (50 ng/ml), LH (50 ng/ml),
IGF-I (100 ng/ml), insulin (100 ng/ml) or Forskolin (1 lg/ml); Tubulin
served as a loading control. Note that FSH and forskolin were able to
stimulate expression of the Star protein. The blots are representative of
three independent experiments.
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ling pathway. Moreover, PTEN expression or activation can
be aﬀected by other molecules than IGFs. For example, in hu-
man endometrial cells, it has been shown recently that estra-
diol is able to dephosphorylate PTEN, likely leading to its
inactivation, whereas progesterone enhances its expression
levels [24].Fig. 5. Time course analysis of IGF-I on PTEN expression and phosphoryla
Granulosa cells from SF were serum-starved for 48 h in the DMEM medium
protein lysates (60 lg) were then submitted to the detection of PTEN, ph
reblotted with antibodies raised against AKT and MAP kinase ERK1/2 to de
The results are represented as the ratio of stimulation as compared with the c
four independent experiments.3.3. Exogenous expression of PTEN aﬀect E2F activity
In vivo, during terminal follicular growth, granulosa cells
proliferate and then undergo diﬀerentiation, an inverse rela-
tionship between both processes being observed. To examine
the consequences of the increase in PTEN expression on cell
cycle, we transfected ovine granulosa cells from SF with a
vector expressing human PTEN, and with vectors containing
ﬁreﬂy luciferase reporter gene driven by E2F responsive-
element or the promoter of the cyclin-dependent kinase
inhibitor (CDKI) p27. Indeed, p27 plays a central role as a
negative regulator of cell cycle progression in a variety of tis-
sues and conditions [25]. The expression of p27 was reported
to be down-regulated by AKT, and expression of dominant
negative AKT in GC is able to 2.6-fold increase the expres-
sion of p27 [8]. Moreover, the cell cycle regulator E2F is also
regulated by AKT. In particular, in the presence of
LY294002, an inhibitor of AKT activity, the E2F transcrip-
tional activity decreases in T cells [26,27]. In contrast, activa-
tion of the PI3K/AKT pathway induces transcription of
Cyclin D1 and the E2F activity in T cells as well as in
NIH3T3 cells [28].
In ovine granulosa cells, over-expression of human PTEN
decreased slightly but signiﬁcantly the phosphorylation state
of AKT (Fig. 6A; P < 0.05; n = 4), and increased and de-
creased P27- and E2F promoter activity, respectively (Fig.
6B; P < 0.05; n = 3). These results suggest that PTEN could in-
hibit cell cycle progression of granulosa cells by modifying E2F
and P27 expression. However, we cannot exclude a post-tran-
scriptional eﬀect of PTEN. Indeed, many studies have shown
that p27 protein levels are regulated by a variety of prolifera-
tive and anti-proliferative signals and it is thought that this
regulation is primarily at the post-transcriptional level
[29,30]. Moreover, PTEN could aﬀect the progression of cell
cycle by inducing other CDKI such p21 or activating/inhibit-
ing other pathway including p53 [31,32]. However, all these
hypothesis need to be validated to better understand the role
of PTEN in the follicular growth. Taken together, our present
data suggest that the increase in expression of PTEN in large
antral follicles, induced by IGF-I but not FSH, would partic-
ipate in the proliferation/diﬀerentiation transition during ter-
minal follicular growth in the sheep.tion of AKT and MAPK ERK1/2 in ovine granulosa cells in vitro. (A)
and then stimulated for 3, 6, 12 or 24 h with 100 ng/ml of IGF-I. Cell
ospho-AKT, and phospho-MAPK ERK1/2. Blots were stripped and
termine total proteins loading. (B) Quantiﬁcation of the immunoblots.
ontrol (unstimulated cells). Values represent the means ± S.E.M. from
Fig. 6. PTEN eﬀects on promoter activity of P27 and E2F in ovine granulosa cells in vitro. (A) Granulosa cells from SF were cultured in the presence
of IGF-I and transfected with PBK-CMV-PTEN sense plasmid (PTEN) as described in Section 2. After 48 h, granulosa cells were lysated. Cell
protein lysates (60 lg) were submitted to the detection of phospho-AKT, and AKT to determine total proteins loading. The results of the
quantiﬁcation of the immunoblots are represented as the ratio of stimulation as compared with the control (PBK-CMV-empty vector (C)). Values
represent the means ± S.E.M. from four independent experiments. (B) Granulosa cells from SF were cultured in the presence of IGF-I and
transfected with a p27 promoter-luciferase construct (n = 3) or an E2F responsive element-luciferase construct (n = 3) in the presence of a PBK-
CMV-empty vector (C), or a PBK-CMV-PTEN sense plasmid (PTEN) as described in Section 2. Luciferase activities of both ﬁreﬂy and renilla were
measured in cell lysates and values were expressed in percentage ± S.E.M. of control. \, P < 0.05, indicates signiﬁcant diﬀerences from control
conditions. In each experiment, measures were obtained as the mean of three replicates.
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